R Vlaicu
About
In The Last Decade
R Vlaicu
33 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 89
- Immunology 828
- Molecular Biology 250
- Epidemiology 238
- Surgery 179
- Cardiology and Cardiovascular Medicine 174
Countries citing papers authored by R Vlaicu
This map shows the geographic impact of R Vlaicu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Vlaicu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Vlaicu more than expected).
Fields of papers citing papers by R Vlaicu
This network shows the impact of papers produced by R Vlaicu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Vlaicu. The network helps show where R Vlaicu may publish in the future.
Co-authorship network of co-authors of R Vlaicu
This figure shows the co-authorship network connecting the top 25 collaborators of R Vlaicu. A scholar is included among the top collaborators of R Vlaicu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Vlaicu. R Vlaicu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 272 | |
| 3 | 11 | |
| 4 | 44 | |
| 5 | 13 | |
| 6 | 13 | |
| 7 | 11 | |
| 8 | 27 | |
| 9 | 29 | |
| 10 | 94 | |
| 11 | 55 | |
| 12 | 13 | |
| 13 | 7 | |
| 14 | 118 | |
| 15 | 7 | |
| 16 | [Serum zinc and copper in patients with atherosclerosis obliterans of the lower limbs]. | 1 |
| 17 | [The effect of some beta-blocking drugs on plasma renin activity, platelet adhesiveness and dilute blood clot lysis time in patients with essential arterial hypertension]. | 1 |
| 18 | Serum electrophoretic lipoprotein factors and pseudocholinesterase activity in thyroid disease. | 4 |
| 19 | [Fever therapy in thromboangiitis obliterans]. | 2 |
| 20 | [The role of rickettsial and pararickettsial diseases in the etiopathogenesis of some chronic arteriopathies]. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.